APA (7th ed.) Citation

Yang, S., Li, J., Mao, S., Zhao, X., Liu, D., Chen, J., . . . Shi, Y. (2026). DNMT2‐m5C‐ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation‐Mediated Notch Pathway. Advanced Science, 13(13), 1. https://doi.org/10.1002/advs.202515931

Chicago Style (17th ed.) Citation

Yang, Shiguang, et al. "DNMT2‐m5C‐ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation‐Mediated Notch Pathway." Advanced Science 13, no. 13 (2026): 1. https://doi.org/10.1002/advs.202515931.

MLA (9th ed.) Citation

Yang, Shiguang, et al. "DNMT2‐m5C‐ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation‐Mediated Notch Pathway." Advanced Science, vol. 13, no. 13, 2026, p. 1, https://doi.org/10.1002/advs.202515931.